C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy-Reference-Cited by-同舟云学术

C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy

Published:2018-04 Issue:4 Volume:93 Page:977-985
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Bomback Andrew S.,Santoriello Dominick,Avasare Rupali S.,Regunathan-Shenk Renu,Canetta Pietro A.,Ahn Wooin,Radhakrishnan Jai,Marasa Maddalena,Rosenstiel Paul E.,Herlitz Leal C.,Markowitz Glen S.,D’Agati Vivette D.,Appel Gerald B.

Publisher

Elsevier BV

Subject

Nephrology

Reference23 articles.

1. C3 glomerulopathy: a new classification;Fakhouri;Nat Rev Nephrol,2010

2. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies;Servais;Kidney Int,2012

3. C3 glomerulopathy: clinicopathologic features and predictors of outcome;Medjeral-Thomas;Clin J Am Soc Nephrol,2014

4. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN;Bomback;Nat Rev Nephrol,2012

5. C3 glomerulopathy: what's in a name?;D'Agati;Kidney Int,2012

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases;Clinical Kidney Journal;2024-07-10

2. Unsupervised Clustering of Membranoproliferative Glomerulonephritis and C3 Glomerulopathy Patients Discovers Distinct Patient Groups unlike the Current Classification;Nephron;2024-07-04

3. Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use;Clinical Kidney Journal;2024-06-20

4. C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First Two Years Post-Transplantation;Clinical Journal of the American Society of Nephrology;2024-06-07

5. Developing Therapies for C3 Glomerulopathy;Clinical Journal of the American Society of Nephrology;2024-06-03